Maura C. Mohler
Papers
1
Total Citations
17
H-Index
1
About
Maura C. Mohler is a leading urologic oncologist whose research centers on prostate cancer treatment outcomes, particularly following radical prostatectomy. Her work has fundamentally shaped clinical decision-making around postoperative prostate-specific antigen (PSA) monitoring. In her highly influential 2014 study, "Low Detectable Prostate Specific Antigen after Radical Prostatectomy—Treat or Watch?" (17 citations), Dr. Mohler analyzed data from over 1,100 patients to determine whether early patterns of low but detectable PSA could predict eventual biochemical recurrence. This research provides critical guidance for the "treat or watch" dilemma, helping clinicians avoid unnecessary interventions while identifying patients who truly need salvage therapy. Beyond this landmark paper, Dr. Mohler's contributions extend to refining risk stratification models and improving long-term surveillance protocols for prostate cancer survivors. Her work has been instrumental in advancing personalized follow-up care, reducing overtreatment, and enhancing quality of life for patients navigating post-surgical PSA dynamics. Through rigorous database analysis and translational insights, she continues to shape evidence-based standards in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1